Back to Journals » OncoTargets and Therapy » Volume 8

A spectrum of cutaneous toxicities from erlotinib may be a robust clinical marker for non-small-cell lung therapy: a case report and literature review

Total article views   HTML views PDF downloads Totals
10,449 Dovepress* 9,853+ 1,803 11,656
PubMed Central* 596 225 821
Totals 10,449 2,028 12,477
*Since 23 April 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar